News | January 05, 2015

ProCure Proton Therapy Center in New Jersey Celebrates 1,000th Patient

Major milestone marks greater access to proton therapy both locally and abroad

January 5, 2015 — Zelina Amir was the 1,000th patient to complete treatment at the ProCure Proton Therapy Center in Somerset, New Jersey. Amir, who traveled to ProCure from Israel, was treated for a hemangioblastoma of the spine.

Proton therapy is a precise form of radiation that directly attacks tumors while minimizing potentially damaging radiation to surrounding healthy tissues and organs, and is beneficial for difficult-to-reach tumors and complex cases.

After getting in a car accident in 2006, a CT scan found a small tumor in Amir's spine, but it was recommended at that time that it not be treated by any means due to its sensitive location. In 2011, Amir was diagnosed with breast cancer, and it was then discovered that her hemangioblastoma tumor had grown larger and now mandated treatment. Since 2012, Amir has had five surgeries on her spine, only for the tumor to grow back. Amir’s doctors in Israel told her about proton therapy and ProCure, feeling strongly that it was the key to her recovery.

Studies have shown proton therapy to be effective in treating many types of cancers, including tumors of the brain, gastrointestinal system, head and neck region and prostate, as well as sarcomas and most pediatric cancers. The precision of proton therapy makes it especially effective for treating children and adults with anatomically complex tumors, such as tumors that are inoperable, located at the base of the skull, or along the spinal cord.

For more information: www.procure.com

 

Related Content

Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
MedStar Georgetown Conducts World's First Hyperscan Proton Therapy Treatment
News | Proton Therapy | April 27, 2018
For the first time, cancer patients in the Washington, D.C. metropolitan region have access to proton therapy, now...
First Patient Treated on Mevion's S250i Proton Therapy System
News | Proton Therapy | April 05, 2018
Mevion Medical Systems announced the treatment of the first patient in the world on the Mevion S250i Proton Therapy...
MEDraysintell released a report in January revising its projection for the number of proton therapy centers worldwide by 2030 down from 1,200 to 900. The company said that more than 50 proton therapy treatment rooms would need to be opened every year from 2018 to 2030 to hit the original projection of 1,200.

MEDraysintell released a report in January revising its projection for the number of proton therapy centers worldwide by 2030 down from 1,200 to 900. The company said that more than 50 proton therapy treatment rooms would need to be opened every year from 2018 to 2030 to hit the original projection of 1,200.

Feature | Proton Therapy | March 06, 2018 | By Jeff Zagoudis
Proton therapy has experienced major growth in the last decade, but that growth seems to have slowed slightly in recent...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
RayStation Selected for India’s First Proton Center
News | Proton Therapy | February 01, 2018
February 1, 2018 – Apollo Hospitals, Asia´s foremost integrated healthcare provider, has selected RayStation for a ne
IBA Announces First Patient Treated with Proteus PLUS in The Netherlands
News | Proton Therapy | January 25, 2018
January 25, 2018 –  IBA (Ion Beam Applications SA) has announced that the University Medical Center Groningen (UMCG)
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
Overlay Init